DongKoo Bio & Pharma Co., Ltd. (KOSDAQ:006620)
5,370.00
-10.00 (-0.19%)
At close: Apr 20, 2026
DongKoo Bio & Pharma Market Cap
DongKoo Bio & Pharma has a market cap or net worth of 141.97 billion as of April 21, 2026. Its market cap has decreased by -0.19% in one year.
Market Cap
141.97B
Enterprise Value
236.05B
Revenue
242.69B
Ranking
n/a
PE Ratio
2.93
Stock Price
5,370.00
Market Cap Chart
Since February 19, 2018, DongKoo Bio & Pharma's market cap has decreased from 369.75B to 141.97B, a decrease of -61.60%. That is a compound annual growth rate of -11.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 145.22B | -1.83% |
| Dec 30, 2025 | 147.92B | 12.87% |
| Dec 30, 2024 | 131.05B | -16.18% |
| Dec 28, 2023 | 156.35B | -7.82% |
| Dec 29, 2022 | 169.61B | -27.07% |
| Dec 30, 2021 | 232.56B | -3.34% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 19, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vivozon Pharmaceutical | 194.33B |
| OPTUS Pharmaceutical | 187.41B |
| Organoidsciences | 155.09B |
| Kyung Dong Pharmaceutical | 154.11B |
| PHARMARESEARCH BIO | 140.47B |
| KOREA PHARMA | 132.84B |
| HYUNDAI BIOLAND | 131.40B |
| WITHUS PHARMACEUTICAL Co.,LTD. | 126.34B |